These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 708008)

  • 1. Pharmacokinetics of azlocillin in persons with normal and impaired renal functions.
    Fiegel P; Becker K
    Antimicrob Agents Chemother; 1978 Sep; 14(3):288-91. PubMed ID: 708008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of the pharmacokinetics and dose dependency of azlocillin in normal subjects and patients with renal insufficiency.
    Bergan T
    J Antimicrob Chemother; 1983 May; 11 Suppl B():101-14. PubMed ID: 6352598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical pharmacokinetics of azlocillin].
    Singlas E; Haegel C
    Presse Med; 1984 Mar; 13(13):788-96. PubMed ID: 6231596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of azlocillin in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Godin M; Fillastre JP
    Antimicrob Agents Chemother; 1980 Mar; 17(3):344-9. PubMed ID: 7425600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of azlocillin in chronic renal failure and hemodialysis patients].
    Fillastre JP; Humbert G; Leroy A; Godin M
    Presse Med; 1984 Mar; 13(13):797-801. PubMed ID: 6231597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic interactions between azlocillin, cefotaxime, and cefotaxime metabolites in normal and impaired renal function.
    Kampf D; Borner K; Möller M; Kessel M
    Clin Pharmacol Ther; 1984 Feb; 35(2):214-20. PubMed ID: 6319069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics of azlocillin in impaired renal function and haemodialysis (author's transl)].
    Schurig R; Kampf D; Becker H; Förster D
    Arzneimittelforschung; 1979; 29(12a):1944-8. PubMed ID: 543896
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of azlocillin in healthy subjects.
    Leroy A; Humbert G; Fillastre JP
    Scand J Infect Dis Suppl; 1981; 29():49-54. PubMed ID: 6947405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mezlocillin pharmacokinetics in patients with normal and impaired renal functions.
    Bergan T; Brodwall EK; Wiik-Larsen E
    Antimicrob Agents Chemother; 1979 Nov; 16(5):651-4. PubMed ID: 526008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of impaired renal function, hemodialysis, and peritoneal dialysis on the pharmacokinetics of mezlocillin.
    Kampf D; Schurig R; Weihermüller K; Förster D
    Antimicrob Agents Chemother; 1980 Jul; 18(1):81-7. PubMed ID: 6448024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of azlocillin in normal renal function: single and repetitive dosing studies.
    Delgado FA; Stout RL; Whelton A
    J Antimicrob Chemother; 1983 May; 11 Suppl B():79-88. PubMed ID: 6619035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics after discontinuous intravenous administration of azlocillin].
    Naber K; Adam D
    Arzneimittelforschung; 1983; 33(3):429-32. PubMed ID: 6683518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elimination of azlocillin in patients with biliary t-tube drainage.
    Gundert-Remy U; Weber E
    Eur J Clin Pharmacol; 1982; 22(5):435-9. PubMed ID: 7117356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An azlocillin dosing nomogram for renal insufficiency.
    Whelton A; Stout RL; Delgado FA
    J Antimicrob Chemother; 1983 May; 11 Suppl B():97-9. PubMed ID: 6619037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics of azlocillin in the burn patient].
    Drugeon HB; Pannier M; Courtieu AL
    Presse Med; 1984 Mar; 13(13):805-7. PubMed ID: 6231599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Azlocillin--a new anti-pseudomonas penicillin. A review of the literature and pharmacokinetic studies].
    Modr Z; Dvorácek K; Janků I; Krebs V
    Infection; 1982; 10 Suppl 3():S184-90. PubMed ID: 7152688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azlocillin treatment of urinary tract infection in patients on haemodialysis.
    Hallan H; Svarva PL; Svartås TM; Widerøe T
    Scand J Infect Dis Suppl; 1981; 29():55-8. PubMed ID: 6947406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of azlocillin in children with cystic fibrosis.
    Bergan T; Michalsen H
    Arzneimittelforschung; 1979; 29(12a):1955-7. PubMed ID: 543899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of azlocillin after discontinuous intravenous administration of high dose.
    Naber KG; Adam D
    J Antimicrob Chemother; 1983 May; 11 Suppl B():115-20. PubMed ID: 6619021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of acylureidopenicillin pharmacokinetics.
    Bergan T
    Scand J Infect Dis Suppl; 1981; 29():33-48. PubMed ID: 7031864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.